Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue	$ 2,683,597	$ 1,604,069
Cost of goods sold	4,774,784	1,770,552
Gross loss	(2,091,187)	(166,483)
Operating expenses:
Research and development	11,449,617	1,920,548
Sales and marketing	2,419,168	1,415,282
General and administrative	17,168,898	6,603,935
Total operating expenses	31,037,683	9,939,765
Loss from operations	(33,128,870)	(10,106,248)
Other income (expense):
Other income, net	51,768	236,923
Interest expense	(2,312)	(327,196)
Loss on extinguishment of debt		(566,925)
Total other income (expense), net	49,456	(657,198)
Net loss	(33,079,414)	(10,763,446)
Provision for income taxes
Deemed dividend on modification of Series H-5 warrants		(432,727)
Net loss Attributable to Common Stockholders	$ (33,079,414)	$ (11,196,173)
Net loss per share, basic and diluted	$ (0.94)	$ (0.73)
Basic and diluted weighted average Common Stock outstanding	35,171,935	15,336,617